Table 4.
Event | Group | aHR* (95% CI) |
---|---|---|
Primary Composite Outcome | ||
Primary composite outcome | Ablation | 0.95 (0.60, 1.52) |
Drug | 0.69 (0.43, 1.11) | |
Primary Outcome Components | ||
Death | Ablation | 0.67 (0.37, 1.22) |
Drug | 0.99 (0.56, 1.73) | |
Disabling Stroke | Ablation | 3.44 (0.27, 43.85) |
Drug | 0.74 (0.12, 4.71) | |
Serious Bleeding | Ablation | 1.10 (0.53, 2.28) |
Drug | 0.39 (0.17, 0.91) | |
Cardiac Arrest | Ablation | 4.86 (0.92, 25.66) |
Drug | 0.44 (0.05, 3.93) | |
AF recurrence | Ablation | 1.19 (0.93, 1.53) |
Drug | 0.89 (0.70, 1.13) | |
Secondary Outcomes | ||
Death or CV hospitalization | Ablation | 1.03 (0.85, 1.24) |
Drug | 0.95 (0.79, 1.13) |
aHR: adjusted hazard ratio with male group as a reference.